Eads & Heald Wealth Management Buys 19,187 Shares of Lam Research Co. (NASDAQ:LRCX)

Eads & Heald Wealth Management boosted its stake in shares of Lam Research Co. (NASDAQ:LRCX) by 864.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,407 shares of the semiconductor company’s stock after purchasing an additional 19,187 shares during the quarter. Eads & Heald Wealth Management’s holdings in Lam Research were worth $1,546,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Van ECK Associates Corp lifted its stake in shares of Lam Research by 1,394.7% in the third quarter. Van ECK Associates Corp now owns 16,081,071 shares of the semiconductor company’s stock valued at $13,123,440,000 after buying an additional 15,005,178 shares during the period. Assenagon Asset Management S.A. acquired a new position in Lam Research in the 4th quarter valued at approximately $175,652,000. Guinness Asset Management LTD lifted its position in shares of Lam Research by 1,129.8% in the 4th quarter. Guinness Asset Management LTD now owns 482,156 shares of the semiconductor company’s stock worth $34,825,000 after acquiring an additional 442,949 shares during the period. ARS Investment Partners LLC grew its holdings in shares of Lam Research by 908.9% during the 4th quarter. ARS Investment Partners LLC now owns 490,881 shares of the semiconductor company’s stock worth $35,456,000 after purchasing an additional 442,224 shares in the last quarter. Finally, Nisa Investment Advisors LLC bought a new stake in shares of Lam Research during the fourth quarter valued at approximately $31,060,000. 84.61% of the stock is currently owned by institutional investors and hedge funds.

Lam Research Stock Performance

LRCX stock opened at $81.50 on Wednesday. The stock has a market capitalization of $104.87 billion, a PE ratio of 26.34, a price-to-earnings-growth ratio of 1.48 and a beta of 1.45. The company has a debt-to-equity ratio of 0.53, a current ratio of 2.53 and a quick ratio of 1.74. The company has a 50 day moving average price of $74.81 and a 200 day moving average price of $80.43. Lam Research Co. has a fifty-two week low of $68.87 and a fifty-two week high of $113.00.

Lam Research (NASDAQ:LRCX) last issued its quarterly earnings results on Wednesday, October 23rd. The semiconductor company reported $0.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.81 by $0.05. The business had revenue of $4.17 billion for the quarter, compared to analyst estimates of $4.06 billion. Lam Research had a return on equity of 50.60% and a net margin of 26.02%. The firm’s revenue for the quarter was up 19.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $6.85 earnings per share. Analysts forecast that Lam Research Co. will post 3.51 EPS for the current year.

Lam Research Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, January 8th. Stockholders of record on Wednesday, December 11th were paid a $0.23 dividend. This represents a $0.92 annualized dividend and a dividend yield of 1.13%. The ex-dividend date was Wednesday, December 11th. Lam Research’s dividend payout ratio (DPR) is presently 29.74%.

Wall Street Analysts Forecast Growth

LRCX has been the subject of several research reports. Barclays reduced their target price on Lam Research from $90.00 to $75.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. Mizuho decreased their target price on shares of Lam Research from $95.00 to $90.00 and set an “outperform” rating on the stock in a research report on Friday, January 10th. Needham & Company LLC reissued a “buy” rating and issued a $100.00 price target on shares of Lam Research in a research report on Thursday, October 24th. B. Riley cut their price target on shares of Lam Research from $132.50 to $105.00 and set a “buy” rating for the company in a research note on Wednesday, October 23rd. Finally, Cantor Fitzgerald reiterated a “neutral” rating and issued a $100.00 price objective on shares of Lam Research in a research note on Thursday, October 24th. Nine equities research analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $95.77.

Lam Research Company Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.